Mark W. Hahn - 29 Aug 2025 Form 4 Insider Report for Verona Pharma plc (VRNA)

Role
Chief Financial Officer
Signature
/s/ Andrew Fisher, Attorney-in-fact for Mark Hahn
Issuer symbol
VRNA
Transactions as of
29 Aug 2025
Net transactions value
$0
Form type
4
Filing time
03 Sep 2025, 16:30:15 UTC
Previous filing
05 Aug 2025
Next filing
08 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hahn Mark W Chief Financial Officer 3 MORE LONDON RIVERSIDE, LONDON, UNITED KINGDOM /s/ Andrew Fisher, Attorney-in-fact for Mark Hahn 03 Sep 2025 0001408502

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRNA Ordinary Shares Gift $0 -1,200,000 -9.6% $0.000000 11,264,968 29 Aug 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
F2 Consists of (i) 2,375,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 296,875 ADSs); and (ii) 8,889,968 Ordinary Shares underlying 1,111,246 ADSs.